scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.0906-6705.2005.00307.X |
P698 | PubMed publication ID | 15810885 |
P2093 | author name string | Hiroyuki Matsue | |
Masahiro Kusuhara | |||
P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells | Q28184794 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Tolerogenic dendritic cells | Q29618755 | ||
Direct and indirect recognition: the role of MHC antigens in graft rejection | Q33546858 | ||
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance | Q33897693 | ||
Dendritic cells in cancer immunotherapy | Q33932695 | ||
Designer dendritic cells for tolerance induction: guided not misguided missiles | Q34319943 | ||
Dendritic cell-based immunoregulatory strategies | Q34647206 | ||
Dendritic cells: a journey from laboratory to clinic | Q35618115 | ||
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo | Q36236655 | ||
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo | Q36375923 | ||
Reduction of antiviral CD8 lymphocytes in vivo with dendritic cells expressing Fas ligand-increased survival of viral (lymphocytic choriomeningitis virus) central nervous system infection | Q40695601 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells | Q40766964 | ||
A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival | Q40882028 | ||
Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells | Q40938855 | ||
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness | Q40981826 | ||
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites | Q42971765 | ||
Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro | Q44321933 | ||
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
P433 | issue | 4 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 273-280 | |
P577 | publication date | 2005-04-01 | |
P1433 | published in | Experimental Dermatology | Q15749509 |
P1476 | title | Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections | |
P478 | volume | 14 |
Q38119559 | Adoptive transfusion of tolerance dendritic cells prolongs the survival of skin allografts in mice: a systematic review |
Q50526246 | Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells. |
Q26739998 | Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews |
Q57384575 | Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity |
Search more.